Gene · 4036
Papers3,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrated analysis of the cancer genome atlas data discovers a hierarchical association structure across thirty three cancer types. | PLOS Digit Health | 2022 | 36812605 | PubTator, text mining | PubMed |
| Endogenous markers of kidney function and renal drug clearance processes of filtration, secretion, and reabsorption. | Curr Opin Toxicol | 2022 | 36777447 | PubTator, text mining | PubMed |
| Quantitative plasma proteomics identifies metallothioneins as a marker of acute-on-chronic liver failure associated acute kidney injury. | Front Immunol | 2022 | 36776389 | PubTator, text mining | PubMed |
| EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis. | Front Oncol | 2022 | 36727065 | PubTator, text mining | PubMed |
| Identification of lymph node metastasis-related genes and patterns of immune infiltration in colon adenocarcinoma. | Front Oncol | 2022 | 36727052 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor from retinal pigment epithelium is essential in choriocapillaris and axial length maintenance. | PNAS Nexus | 2022 | 36714840 | PubTator, text mining | PubMed |
| Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. | Front Pharmacol | 2022 | 36712680 | PubTator, text mining | PubMed |
| The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. | Biomolecules | 2022 | 36671447 | PubTator, text mining | PubMed |
| Curcuminoid supplementation in canine diabetic mellitus and its complications using proteomic analysis. | Front Vet Sci | 2022 | 36619946 | PubTator, text mining | PubMed |
| Posterior Polymorphous Corneal Dystrophy in a Patient with a Novel ZEB1 Gene Mutation. | Int J Mol Sci | 2022 | 36613650 | PubTator, text mining | PubMed |
| Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option. | Int J Mol Sci | 2022 | 36613613 | PubTator, text mining | PubMed |
| Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. | Cancers (Basel) | 2022 | 36612212 | PubTator, text mining | PubMed |
| Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. | Cancers (Basel) | 2022 | 36612154 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Megalin Orchestrates FcRn Endocytosis and Trafficking. | Cells | 2022 | 36611847 | PubTator, text mining | PubMed |
| Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. | Front Immunol | 2022 | 36591255 | PubTator, text mining | PubMed |
| Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health. | Front Nutr | 2022 | 36583209 | PubTator, text mining | PubMed |
| A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. | Cell Biosci | 2022 | 36581992 | PubTator, text mining | PubMed |
| Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus. | Transl Vis Sci Technol | 2022 | 36580321 | PubTator, text mining | PubMed |
| The Efficacy of Vitamin D Supplementation in Patients With Alzheimer's Disease in Preventing Cognitive Decline: A Systematic Review. | Cureus | 2022 | 36569670 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4036/papers?page=29